Panoscreen I, II, and III Reagent Red Blood Cell, 2-4% Suspension
Standard priority
The issue
Performance
Affected product
Panoscreen I, II, and III Reagent Red Blood Cell, 2-4% Suspension
Where it was sold
Canada (national)Reported in the official notice — confirm there.
Issued by
Health Canada — Medical devices
Read the official Government of Canada notice
All recallsRecallGuardian ranks, illustrates and rewrites recalls in plain language. The official notice is authoritative — confirm model numbers, lot codes, dates and remedies there.